以测量间百分比变化衡量的血糖变异性可预测动脉瘤性蛛网膜下腔出血的住院死亡率
该研究纳入2002至2016年单中心2451例行动脉瘤性蛛网膜下腔出血且血糖测量超过2次的住院患者,计算多种血糖变异性指标并分析其与住院死亡率的关系。多因素回归显示几乎所有变异性指标均与住院死亡率相关,其中连续绝对百分比变化预测性最强(百分比变化OR 5.2,95%CI 1.4-19.8;中位数变化OR 8.8,95%CI 1.8-43.6)。存活至ICU出院者连续绝对百分比变化为17%±9%,低于未存活者的20%±15%(P<0.01)。该关联在入院前HbA1c提示糖尿病控制不佳的患者中不显著(OR 0.45,95%CI 0.04-7.18),效应主要由非糖尿病或糖尿病控制良好患者驱动。作者认为减少血糖变异性与生存相关,提示可基于基线HbA1c制定个体化血糖目标并最小化变异性。
要点
- 在2451例动脉瘤性蛛网膜下腔出血患者中,连续绝对百分比变化衡量的血糖变异性预测住院死亡率最强:百分比变化OR 5.2(95%CI 1.4-19.8),中位数变化OR 8.8(95%CI 1.8-43.6)。
- 存活至ICU出院者连续绝对百分比变化为17%±9%,未存活者为20%±15%(P<0.01),存活者血糖变异性更低。
- 在入院前HbA1c提示糖尿病控制不佳的患者中,血糖变异性与住院死亡率的关联不显著(OR 0.45,95%CI 0.04-7.18)。
- 血糖变异性与不良结局的关联主要由非糖尿病或糖尿病控制良好的动脉瘤性蛛网膜下腔出血患者驱动。
- 测量间百分比变化作为血糖变异性指标简便易用,作者认为可基于基线HbA1c制定个体化血糖目标并最小化变异性。
适用人群与场景
- 2002至2016年单中心收治的动脉瘤性蛛网膜下腔出血患者,且血糖测量次数超过2次(n=2451)。
研究设计与关键结果
- 研究类型为单中心回顾性分析,纳入2002至2016年2451例血糖测量超过2次的动脉瘤性蛛网膜下腔出血患者,主要结局为住院死亡率。
- 多因素回归分析中,几乎所有血糖变异性计算方式均与住院死亡率相关;连续绝对百分比变化预测性最强:百分比变化OR 5.2(95%CI 1.4-19.8),中位数变化OR 8.8(95%CI 1.8-43.6),均校正了入院Hunt-Hess分级、年龄、性别、心血管危险因素和手术治疗。
- 存活至ICU出院者连续绝对百分比变化为17%±9%,未存活至出院者为20%±15%(P<0.01)。
- 在入院前HbA1c提示糖尿病控制不佳的患者中,血糖变异性与住院死亡率的关联不显著(百分比变化OR 0.45,95%CI 0.04-7.18)。
- 血糖变异性与不良结局的关联主要由非糖尿病或糖尿病控制良好的患者驱动。
证据类型、等级与局限
- 证据类型:单中心回顾性分析。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,基于基线HbA1c制定个体化血糖目标并最小化血糖变异性可能对动脉瘤性蛛网膜下腔出血患者有益。
- 测量间百分比变化作为血糖变异性指标不仅可预测结局,而且是一种易于使用的工具,可用于未来临床试验。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Critically ill aneurysmal subarachnoid hemorrhage (aSAH) patients suffer from systemic complications at a high rate. Hyperglycemia is a common intensive care unit (ICU) complication and has become a focus after aggressive glucose management was associated with improved ICU outcomes. Subsequent research has suggested that glucose variability, not a specific blood glucose range, may be a more appropriate clinical target. Glucose variability is highly correlated to poor outcomes in a wide spectrum of critically ill patients. Here, we investigate the changes between subsequent glucose values termed "inter-measurement difference," as an indicator of glucose variability and its association with outcomes in patients with aSAH.
METHODS: All SAH admissions to a single, tertiary referral center between 2002 and 2016 were screened. All aneurysmal cases who had more than 2 glucose measurements were included (n = 2451). We calculated several measures of variability, including simple variance, the average consecutive absolute change, average absolute change by time difference, within subject variance, median absolute deviation, and average or median consecutive absolute percentage change. Predictor variables also included admission Hunt and Hess grade, age, gender, cardiovascular risk factors, and surgical treatment. In-patient mortality was the main outcome measure.
RESULTS: In a multiple regression analysis, nearly all forms of glucose variability calculations were found to be correlated with in-patient mortality. The consecutive absolute percentage change, however, was most predictive: OR 5.2 [1.4-19.8, CI 95%] for percentage change and 8.8 [1.8-43.6] for median change, when controlling for the defined predictors. Survival to ICU discharge was associated with lower glucose variability (consecutive absolute percentage change 17% ± 9%) compared with the group that did not survive to discharge (20% ± 15%, p < 0.01). Interestingly, this finding was not significant in patients with pre-admission poorly controlled diabetes as indicated by HbA1c (OR 0.45 [0.04-7.18], by percentage change). The effect is driven mostly by non-diabetic patients or those with well-controlled diabetes.
CONCLUSIONS: Reduced glucose variability is highly correlated with in-patient survival and long-term mortality in aSAH patients. This finding was observed in the non-diabetic and well-controlled diabetic patients, suggesting a possible benefit for personalized glucose targets based on baseline HbA1c and minimizing variability. The inter-measure percentage change as an indicator of glucose variability is not only predictive of outcome, but is an easy-to-use tool that could be implemented in future clinical trials.
参考来源
- Sadan O, Feng C, Vidakovic B, et al. Glucose Variability as Measured by Inter-measurement Percentage Change is Predictive of In-patient Mortality in Aneurysmal Subarachnoid Hemorrhage. Neurocrit Care. 2020. PMID: 31933216. doi:10.1007/s12028-019-00906-1
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。